Theraclion SA (EPA:ALTHE)
France · Delayed Price · Currency is EUR 0.6470
-0.0110 (-1.67%)
Aug 21, 2026, 5:35 PM CET
Theraclion Market Cap
Theraclion has a market cap or net worth of €47.3 million as of August 21, 2026. Its market cap has increased by 52.54% in one year.
Market Cap
47.30M
Enterprise Value
55.15M
Revenue
652.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.65
ChartMarket Cap Chart
Since April 25, 2014, Theraclion's market cap has increased from 37.53M to 47.30M, an increase of 26.03%. That is a compound annual growth rate of 1.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 47.30M | 67.23% |
| Dec 31, 2025 | 28.28M | 85.64% |
| Dec 31, 2024 | 15.24M | -11.33% |
| Dec 29, 2023 | 17.18M | -34.28% |
| Dec 30, 2022 | 26.15M | -12.29% |
| Dec 31, 2021 | 29.81M | -3.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Carvolix | 363.76M |
| Eurobio Scientific Société anonyme | 204.39M |
| Median Technologies | 173.46M |
| Guerbet | 101.05M |
| Novacyt | 37.19M |
| Mauna Kea Technologies | 30.28M |
| Implanet | 27.01M |
| Diagnostic Medical Systems | 26.95M |